Group One Trading’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-200
| Closed | -$904 | – | 7831 |
|
|
2025
Q4 | $904 | Sell |
200
-43,200
| -100% | -$221K | ﹤0.01% | 7726 |
|
|
2025
Q3 | $234K | Sell |
43,400
-34,100
| -44% | -$185K | ﹤0.01% | 4513 |
|
|
2025
Q2 | $421K | Buy |
77,500
+31,400
| +68% | +$125K | ﹤0.01% | 3590 |
|
|
2025
Q1 | $128K | Buy |
46,100
+30,600
| +197% | +$106K | ﹤0.01% | 4415 |
|
|
2024
Q4 | $52.9K | Buy |
15,500
+6,300
| +68% | +$18.2K | ﹤0.01% | 5012 |
|
|
2024
Q3 | $27K | Sell |
9,200
-3,300
| -26% | -$10.9K | ﹤0.01% | 5065 |
|
|
2024
Q2 | $42.5K | Buy |
12,500
+100
| +0.8% | +$327 | ﹤0.01% | 4632 |
|
|
2024
Q1 | $37.6K | Sell |
12,400
-59,500
| -83% | -$209K | ﹤0.01% | 4950 |
|
|
2023
Q4 | $303K | Sell |
71,900
-77,600
| -52% | -$421K | ﹤0.01% | 3499 |
|
|
2023
Q3 | $1.02M | Buy |
149,500
+82,600
| +123% | +$730K | ﹤0.01% | 2252 |
|
|
2023
Q2 | $697K | Buy |
66,900
+43,400
| +185% | +$388K | ﹤0.01% | 2686 |
|
|
2023
Q1 | $164K | Sell |
23,500
-22,700
| -49% | -$198K | ﹤0.01% | 3852 |
|
|
2022
Q4 | $279K | Buy |
46,200
+15,600
| +51% | +$115K | ﹤0.01% | 3568 |
|
|
2022
Q3 | $241K | Sell |
30,600
-127,700
| -81% | -$1.49M | ﹤0.01% | 3956 |
|
|
2022
Q2 | $2.15M | Buy |
158,300
+65,500
| +71% | +$1.08M | ﹤0.01% | 1990 |
|
|
2022
Q1 | $1.82M | Sell |
92,800
-59,900
| -39% | -$1.2M | ﹤0.01% | 2492 |
|
|
2021
Q4 | $5.24M | Sell |
152,700
-181,200
| -54% | -$7.29M | ﹤0.01% | 1665 |
|
|
2021
Q3 | $18.2M | Sell |
333,900
-216,800
| -39% | -$13.1M | 0.02% | 669 |
|
|
2021
Q2 | $40.5M | Buy |
550,700
+237,500
| +76% | +$23.7M | 0.05% | 316 |
|
|
2021
Q1 | $28.6M | Buy |
313,200
+278,700
| +808% | +$27M | 0.04% | 394 |
|
|
2020
Q4 | $2.8M | Buy |
34,500
+28,800
| +505% | +$2.2M | ﹤0.01% | 1765 |
|
|
2020
Q3 | $265K | Buy |
+5,700
| New | +$318K | ﹤0.01% | 3424 |
|
Group One Trading's CVAC Position: Q1 2026 in Review
Group One Trading sold out of CureVac (CVAC) in Q1 2026, closing a stake of 1,050 shares — an estimated $4.75K sold.
Group One Trading first reported a position in CVAC in Q4 2020 and held it in 19 quarters. The position peaked at $11.8M in Q3 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Group One Trading reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 1,050 CureVac shares in Q1 2026, an estimated $4.75K.
- Group One Trading first reported a position in CureVac in Q4 2020 and held it in 19 quarters.
- Group One Trading's CureVac position peaked at $11.8M in Q3 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.